Research / TOST / Fundamental state Inspectable configuration
State dimensions Filing 0001650164-26-000164 General Corporate
Capex intensity 33th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.73% · OPTIONAL · VALID
Operating cash generation 67th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.55% · OPTIONAL · VALID
Revenue growth 7th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
23.10% · CORE · VALID
Inventory pressure 89th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.37% · OPTIONAL · VALID
Gross margin 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
27.04% · CORE · VALID
Operating margin 100th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
7.97% · CORE · VALID
R&D intensity 0th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.71% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.88% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.04%
Current 0.73%
Delta -0.31% Cash Generation Decreased
Previous 8.10%
Current 7.55%
Delta -0.55% Growth Increased
Previous 21.91%
Current 23.10%
Delta 1.18% Inventory Pressure Increased
Previous 8.34%
Current 11.37%
Delta 3.03% Margin Decreased
Previous 27.42%
Current 27.04%
Delta -0.38% Profitability Increased
Previous 6.75%
Current 7.97%
Delta 1.22% R And D Intensity Decreased
Previous 5.95%
Current 5.71%
Delta -0.24% Sbc Intensity Decreased
Previous 3.31%
Current 2.88%
Delta -0.43% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2025
Similarity 83%
Compared 8 dimensions
Coverage 100% Growth 7.1 · Margin 5.6 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 20.5 · Cash Generation 10.3 · R And D Intensity 0.0 · Inventory Pressure 42.7 Mar 31, 2026
Similarity 81%
Compared 8 dimensions
Coverage 100% Growth 7.1 · Margin 5.6 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 43.1 · Cash Generation 3.9 · R And D Intensity 5.9 · Inventory Pressure 30.1 Sep 30, 2025
Similarity 75%
Compared 8 dimensions
Coverage 100% Growth 11.0 · Margin 5.6 · Profitability 6.7 · Sbc Intensity 6.7 · Capex Intensity 6.7 · Cash Generation 26.7 · R And D Intensity 6.7 · Inventory Pressure 62.2 Mar 31, 2024
Similarity 74%
Compared 7 dimensions
Coverage 88% Margin 5.6 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 66.7 · Cash Generation 11.1 · R And D Intensity 0.0 · Inventory Pressure 11.1 Sep 30, 2024
Similarity 71%
Compared 7 dimensions
Coverage 88% Margin 5.6 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 39.4 · Cash Generation 24.2 · R And D Intensity 0.0 · Inventory Pressure 61.6 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.